Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions
Authors:
- 14 July 2024
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 258, 110065
Abstract
No abstract availableKeywords
All Related Versions
This publication has 55 references indexed in Scilit:
- ( R )-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2 R ,6 R )-HydroxynorketamineBiological Psychiatry, 2017
- Reply to: Antidepressant Actions of Ketamine Versus HydroxynorketamineBiological Psychiatry, 2017
- Antidepressant Actions of Ketamine Versus HydroxynorketamineBiological Psychiatry, 2017
- Effect of Efflux Transporter Inhibition on the Distribution of Fluconazole in the Rat BrainNeurochemical Research, 2017
- The distribution and clearance of (2S,6S)‐hydroxynorketamine, an active ketamine metabolite, in Wistar ratsPharmacology Research & Perspectives, 2015
- Simultaneous and comprehensivein vivoanalysis of cytochrome P450 activity by using a cocktail approach in ratsBiopharmaceutics & Drug Disposition, 2014
- Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral ResponsesBiological Psychiatry, 2013
- An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detectionAnalytical and Bioanalytical Chemistry, 2012
- Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major DepressionBiological Psychiatry, 2012
- Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP)Journal of Pharmaceutical Sciences, 2007